Molecular characterization of cDNA for phospholipase A2-activating protein

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1444, Issue 1, 1999, Pages 125-130

  Chopra, A K ^a   Ribardo, D A ^a   Wood, T G ^a   Prusak, D J ^a   Xu, X J ^a   Peterson, J W ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

3' Rapid amplification of cDNA ends; Anti sense plap oligonucleotide; CDNA cloning sequencing, and expression; Phospholipase A2 activating protein; Phospholipase A2 activating protein cDNA; Reverse transcriptase polymerase chain reaction

Indexed keywords

ARACHIDONIC ACID; CHOLERA TOXIN; COMPLEMENTARY DNA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 ACTIVATING PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ENZYME REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR DYNAMICS; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE TAGGED SITE;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENZYME ACTIVATION; GENE LIBRARY; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASES; PROTEINS;

EID: 0033579973     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(98)00249-8     Document Type: Article

References (18)

1. 2 isoforms as novel drug targets, in: R.R. Ruffolo, M.A. Hollinger (Eds.), Inflammation Mediators and Pathways, CRC Press, New York, 1995, pp. 1-28.
2. 2 expression and inflammation: the relationship with associated disease states, J. Lipid Mediat. 8 (1993) 1-30.
3. 2: role in physiologic and inflammatory processes, J. Lipid Mediat. 8 (1993) 161-167.
4. 2, Am. Rev. Respir. Dis. 143 (1991) 1102-1109.
5. 2 in colonic mucosa of patients with inflammatory bowel disease, Am. J. Gastroenterol. 92 (1997) 289-292.
6. 2 in human atherosclerotic plaques in human arteries, Atheroscleorosis 118 (1995) 173-181.
7. 2 in Clinical Inflammation, Molecular Approaches to Pathophysiology, CRC Press, New York, 1995, pp. 93-124.
8. 2-activating protein, Proc. Natl. Acad. Sci. USA 88 (1991) 5418-5422.
9. 2-activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo, J. Lab. Clin. Med. 116 (1990) 814-825.
10. 2-activating protein and the G protein β-subunits: a new concept of effector protein activation in signal transduction, Trends Biochem. Sci. 18 (1993) 292-293.
11. 2-activating protein, Gene 161 (1995) 237-241.
12. 2-activating protein induces the synthesis of IL-1 and TNF in human monocytes, J. Immunol. 154 (1995) 4027-4031.
13. 2-activating protein, Infect. Immun. 64 (1996) 2137-2143.
14. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J. Seidman, A. Smith, K. Struhl (Eds.), Current Protocols in Molecular Biology, John Wiley and Sons, New York, 1989.
15. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
16. 2-activating protein in idiopathic inflammatory bowel disease, Gut 39 (1996) 698-704.
17. H. Wang, D.C.-H. Shostak, J.J. Lemasters, B. Herman, Down-regulation of HCW9 mRNA in rat-hepatocytes during chemical hypoxia involves both transcriptional and post transcriptional mechanisms, Biochem. Biophys. Res. Commun. 218 (1996) 360-364.
18. Y.F. Liang, J.W. Peterson, C.A. Jackson, J.C. Reitmeyer, Chloroquine inhibition of cholera toxin, FEBS Lett. 275 (1990) 143-145.